KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Change in Taxes (2016 - 2025)

Elevance Health (ELV) has disclosed Change in Taxes for 17 consecutive years, with -$284.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Taxes fell 264.16% to -$284.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$297.0 million, a 173.51% decrease, with the full-year FY2025 number at -$297.0 million, down 173.51% from a year prior.
  • Change in Taxes was -$284.0 million for Q4 2025 at Elevance Health, up from -$616.0 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $839.0 million in Q1 2023 to a low of -$727.0 million in Q2 2022.
  • A 5-year average of -$9.7 million and a median of $14.5 million in 2021 define the central range for Change in Taxes.
  • Biggest YoY gain for Change in Taxes was 160.44% in 2025; the steepest drop was 1180.7% in 2025.
  • Elevance Health's Change in Taxes stood at -$28.0 million in 2021, then crashed by 960.71% to -$297.0 million in 2022, then fell by 21.21% to -$360.0 million in 2023, then surged by 148.06% to $173.0 million in 2024, then plummeted by 264.16% to -$284.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Change in Taxes are -$284.0 million (Q4 2025), -$616.0 million (Q3 2025), and $246.0 million (Q2 2025).